Results 161 to 170 of about 31,162 (213)
Some of the next articles are maybe not open access.
Australian and New Zealand Journal of Medicine, 1981
Abstract: Four cases of severe peripheral neuropathy directly attributable to nitrofurantoin are reported. The neuropathy was not dose‐related and not necessarily associated with abnormal renal function. Recovery was slow, and neither severity nor recovery was related to the total dose of the drug. The pathological changes seen on light microscopy and
C, Yiannikas, J D, Pollard, J G, McLeod
openaire +2 more sources
Abstract: Four cases of severe peripheral neuropathy directly attributable to nitrofurantoin are reported. The neuropathy was not dose‐related and not necessarily associated with abnormal renal function. Recovery was slow, and neither severity nor recovery was related to the total dose of the drug. The pathological changes seen on light microscopy and
C, Yiannikas, J D, Pollard, J G, McLeod
openaire +2 more sources
Clinical Pharmacology and Therapeutics, 1981
Nitrofurantoin (50 mg) was administered in a three-way random crossover design to six healthy men. After a 45-min intravenous infusion the plasma concentration data could be described by a two-compartment open-body model with a terminal t 1/2 of 58.1 +/- 15 min. Oral availability of a tablet was 0.87 +/- 0.13 on a fasting stomach and 0.94 +/- 0.13 when
B, Hoener, S E, Patterson
openaire +2 more sources
Nitrofurantoin (50 mg) was administered in a three-way random crossover design to six healthy men. After a 45-min intravenous infusion the plasma concentration data could be described by a two-compartment open-body model with a terminal t 1/2 of 58.1 +/- 15 min. Oral availability of a tablet was 0.87 +/- 0.13 on a fasting stomach and 0.94 +/- 0.13 when
B, Hoener, S E, Patterson
openaire +2 more sources
Drug Intelligence & Clinical Pharmacy, 1985
For more than 30 years nitrofurantoin has been a widely prescribed and effective agent in the treatment of urinary tract infections. During this time, it has withstood the rigors of constant clinical evaluation and has competed successfully with more recent antibacterial agents.
openaire +2 more sources
For more than 30 years nitrofurantoin has been a widely prescribed and effective agent in the treatment of urinary tract infections. During this time, it has withstood the rigors of constant clinical evaluation and has competed successfully with more recent antibacterial agents.
openaire +2 more sources
Obstetrical & Gynecological Survey, 1989
Nitrofurantoin has been in clinical use for more than 35 years for the treatment of urinary tract infections (UTIs). In particular, it has been used to treat acute uncomplicated UTIs, recurrent urinary tract infections, and asymptomatic bacteriuria of pregnancy. Most recently, it has been used for both prophylaxis and treatment of nosocomial infections
openaire +2 more sources
Nitrofurantoin has been in clinical use for more than 35 years for the treatment of urinary tract infections (UTIs). In particular, it has been used to treat acute uncomplicated UTIs, recurrent urinary tract infections, and asymptomatic bacteriuria of pregnancy. Most recently, it has been used for both prophylaxis and treatment of nosocomial infections
openaire +2 more sources